AMF. The Company has received a valid approval of the AMF pursuant to Section 12 of the Securities Act (Québec) with respect to the Registration Statement and the offering of Placement Shares thereunder, and the AMF has not withdrawn or modified such approval.
Appears in 2 contracts
Sources: Sales Agreement (Theratechnologies Inc.), At Market Issuance Sales Agreement (Acasti Pharma Inc.)
AMF. The Company has received a valid approval of the AMF Autorité des marchés financiers (“AMF”) pursuant to Section 12 of the Securities Act (Québec) with respect to the Registration Statement Base Prospectus, as supplemented by the Prospectus and the offering of Placement Shares thereunder, and the AMF has not withdrawn or modified such approval.
Appears in 1 contract